The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
01-Oct-21
Pending
Undisclosed
Target:
Metro Quarry Group
Acquiror:
Adbri / Barro Group
Advised Myer Family Investments on the sale of the assets of Metro Quarry Group (Victoria’s largest specialist sand quarry) to a joint venture comprising Adbri / Barro Group
13-Jul-21
$94 million
Target:
Youfoodz Holdings Limited
Acquiror:
HelloFresh SE
Advised Youfoodz Holdings Limited, a leading provider of fresh, ready-made meals and other convenience food products, on its cash sale to HelloFresh SE via scheme of arrangement
30-Jun-21
Pending
Undisclosed
Target:
Deltalab
Acquiror:
SCG Packaging Public Company Limited
Advising Deltalab, a leading Spanish laboratory solutions provider with dedicated manufacturing capacity, on the sale of the company to SCG Packaging Public Company Limited, the largest integrated packaging and paper company in Southeast Asia
29-Jun-21
~$122 million
Target:
NobleOak Life
Acquiror:
Avant Mutual
Advised Avant Mutual, an Australian member-owned organization providing medical indemnity insurance products to healthcare practitioners, on the exit of its strategic stake in NobleOak Life via IPO
22-Jun-21
Pending
$8.2 billion
Target:
Milton Corporation
Acquiror:
Washington H. Soul Pattinson
Adviser to Milton Corporation on its merger with Washington H. Soul Pattinson effected via scheme of arrangement
03-Jun-21
Undisclosed
Target:
Le Petit Depot
Acquiror:
Phoon Huat
Advised Le Petit Depot, Singapore’s leading online platform specializing in the sale of European food products, on the sale of a controlling stake to, and strategic partnership with, Phoon Huat
11-Feb-21
Undisclosed
Target:
Alumisource Corporation
Acquiror:
Sims Limited
Advised Sims Limited, a global leader in metal recycling and electronics recovery, on the acquisition of certain commercial and operating assets of Alumisource Corporation
30-Oct-20
$142 million
Target:
Youfoodz Holdings Limited
Acquiror:
N/A
Advised Youfoodz Holdings Limited, a leading provider of fresh, ready-made meals and other convenience food products, on its initial public offering on the Australian Securities Exchange (ASX)
28-Oct-20
Undisclosed
Target:
Easton Investments Limited
Acquiror:
HUB24 Limited
Advising HUB24 Limited (ASX: HUB), a leading specialist investment platform provider, on its proposed acquisition of up to 40% in Easton Investments Limited (ASX: EAS), a leading provider of wealth and accounting solutions. The transaction also included the divestment of HUB24’s subsidiary, Paragem, to Easton
10-Jun-20
$134 million
Target:
Equity stake in Bupa Arabia
Acquiror:
Bupa Ltd.
Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, the largest health insurance provider in the Kingdom of Saudi Arabia
09-Jun-20
$1.02 billion
Target:
LIXIL VIVA
Acquiror:
Arcland Sakamoto
Advising Arcland Sakamoto, a leading owner and operator of large home centers, on the acquisition of LIXIL VIVA, a leading owner and operator of large home centers and a listed subsidiary of LIXIL Group, a leading Japanese manufacturer of building and housing materials
09-Mar-20
$10.6 billion
Target:
Tesco plc’s Thailand and Malaysia businesses
Acquiror:
Charoen Pokphand Group
Advised Tesco plc, a leading UK retailer, on the sale of its Thailand and Malaysia businesses to Charoen Pokphand Group, the Thai conglomerate
03-Mar-20
$NA
Target:
Formation of an incorporated joint venture
Acquiror:
BBI Group
Advised Flinders Mines, an ASX-listed mining exploration and development company, on the formation of an incorporated joint venture with BBI Group, providing a structure for the potential integrated financing and development of Flinders’ Pilbara Iron Ore Project and BBI Group’s Balla Balla rail and port infrastructure project
20-Feb-20
$NA
Target:
Asia and US rights to Physiogel
Acquiror:
LG Household & Health Care
Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the rights to Physiogel Asia and the US to Korea-based LG Household & Health Care Ltd
19-Nov-19
$NA
Target:
New Belgium Brewing
Acquiror:
Lion / Kirin
Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of New Belgium Brewing, a leading US independent craft brewery
18-Sep-19
$NA
Target:
CME Group Inc.
Acquiror:
Bursa Malaysia Berhad
Advised CME Group, Inc., the operator of a leading global derivatives marketplace, on the structured sale of its 25% equity stake in Bursa Malaysia Derivatives Berhad to Bursa Malaysia Berhad
23-Aug-19
$NA
Target:
TT International
Acquiror:
Sumitomo Mitsui Financial Group, Inc.
Advised TT International, a leading independent asset management firm focused on managing high alpha, high conviction active management strategies for institutional investors, on its sale to Sumitomo Mitsui Financial Group, Inc.
02-May-19
$545 million
Target:
Kidman Resources Limited
Acquiror:
Wesfarmers
Advised Kidman Resources, an ASX-listed hard rock lithium mining company, on its sale to Wesfarmers, one of Australia’s largest diversified listed companies
26-Apr-19
$200 million
Target:
Lion's Specialty Cheese division
Acquiror:
Saputo Inc.
Advised Lion, an Australian subsidiary of Kirin and one of Australasia’s leading food and beverage companies, on the sale of its Specialty Cheese division to Saputo, one of the top ten dairy processors in the world
22-Mar-19
$NA
Target:
Four Pillars Gin
Acquiror:
Lion Beer Australia
Advised Lion, an Australian subsidiary of Kirin, on its acquisition of a strategic stake in Four Pillars Gin, Australia’s leading craft gin distillery
19-Mar-19
$NA
Target:
BT Advice
Acquiror:
Viridian Advisory
Advised Westpac, the third largest company in Australia by market capitalization, on its exit of BT Advice and the sale of select assets to Viridian Advisory
19-Dec-18
$NA
Target:
Starpharma Holdings Limited, patented VivaGel BV® product
Acquiror:
ITF Pharma, US subsidiary of Italfarmaco S.p.A.
Advised Starpharma Holdings Limited on a US licensing agreement of its patented VivaGel BV® product with ITF Pharma, a US subsidiary of Italfarmaco S.p.A., a privately held European specialty pharmaceutical company
03-Dec-18
$4.0 billion
Target:
Assets owned by GlaxoSmithKline plc
Acquiror:
Unilever plc / Hindustan Unilever Limited
Advised GlaxoSmithKline plc, the UK listed international pharmaceutical and consumer healthcare company, on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc, and on the merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited
26-Nov-18
$880 million
Target:
Restaurant Brands New Zealand Limited
Acquiror:
Finaccess Capital, S.A. de C.V.
Advised Finaccess Capital, an investment company with a strong presence in the casual dining and quick service restaurant sector, on its 75% partial takeover of Restaurant Brands New Zealand, a corporate franchisee specialising in managing multi-site branded food retail chains (with brands consisting of KFC, Pizza Hut, Taco Bell and Carl’s Jr.)
12-Nov-18
$84 million
Target:
AUB Group Limited
Advised ASX-listed AUB Group, a leading insurance intermediary business operating a network of over 100 insurance brokers and underwriting agencies across Australia and New Zealand, on its fully underwritten entitlement offer to raise A$116mm